Beta Bionics announced the integration of its iLet Bionic Pancreas with Dexcom's G7 15 Day continuous glucose monitor (CGM).

Dexcom has announced that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will launch in the United States on Dec. 1.

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has ...

Dexcom announced the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will ...

It takes two: After making its commercial debut early this year, Dexcom’s latest continuous glucose monitor is wrapping up 2023 by connecting with its first automated insulin pump partner, courtesy of ...

With more than 10 years of pioneering CGM market leadership in AID integration, Dexcom is the most studied CGM brand with AID capabilities and the clear choice for powering AID systems 3,4 The ...

DexCom, Inc. DXCM announced that its latest G7 continuous glucose monitoring (CGM) system can now connect with Tandem Diabetes Care's t:slim X2 insulin pump featuring Control-IQ technology. This ...

On Wednesday, medical device manufacturer Dexcom finally delivered its direct-to-Apple Watch functionality for the G7 CGM. Here's how it works. A constant glucose monitor (CGM) has historically worked ...

New Ontario Drug Benefit (ODB) coverage means eligible Ontarians who take insulin can now benefit from using Dexcom G7 to simplify management of their diabetes. Ontario residents eligible for ODB and ...

* Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.†If your glucose alerts and readings from Dexcom G7 do not match symptoms or expectations, ...